Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 2/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | KCNK18 | Q7Z418 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 2/20 | 0.31 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24728353 | 0.87 | MEN1 (0.37) | PDK2CTSDSIGMAR1 | |
| SCHEMBL24728445 | 0.85 | SIGMAR1 (0.34) | PDK2CTSDSIGMAR1 | |
| SCHEMBL25452127 | 0.85 | SIGMAR1 (0.34) | PDK2CTSDSIGMAR1 | |
| SCHEMBL22797226 | 0.84 | SIGMAR1 (0.36) | SIGMAR1 | |
| SCHEMBL22799493 | 0.82 | MET (0.34) | SIGMAR1 | |
| SCHEMBL24728513 | 0.81 | ALDH1A1 (0.36) | — | |
| SCHEMBL25452135 | 0.80 | PDK2 (0.30) | PDK2 | |
| SCHEMBL23959398 | 0.80 | MAPK14 (0.32) | PDK2 | |
| SCHEMBL24728447 | 0.80 | SIGMAR1 (0.40) | PDK2SIGMAR1 | |
| SCHEMBL25452097 | 0.78 | PDK2 (0.37) | PDK2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| WO-2021213109-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 (CN) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | OCIAD2, AOC2, OCIAD1 | P2RY1 806/4885PDK2 1893/4885KCNK18 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.